Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Jefferies Downgrades SAP to Underperform

Jefferies analyst Charles Brennan downgrades SAP (NYSE:SAP) from Buy to Underperform.
byBenzinga Newsdesk
November 18, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Jefferies analyst Charles Brennan downgrades SAP (NYSE:SAP) from Buy to Underperform.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Why Is Itch-Focused Cara Therapeutics Stock Trading Lower Today?

By Vandana Singh
December 18, 3:23 PM
Cara Therapeutics Inc (NASDAQ: CARA) announced the outcome from the dose-finding Part A of the KIND 1 study evaluating the efficacy and safety of oral difelikefalin as adjunct therapy to topical corticosteroids (TCS) for moderate-to-severe pruritus in adult patients with 

CARA